/**/
RNS Number : 0466G
T.Rowe Price Associates
17 November 2015
 

                                                                                                                                                                 FORM 8.3

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2007 (AS AMENDED)

 

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES

REPRESENTING 1% OR MORE

 

1.         KEY INFORMATION

 

Name of person dealing  (Note 1)

T. ROWE PRICE ASSOCIATES, INC.

Company dealt in

PFIZER INC
Class of relevant security to which the dealings being disclosed relate (Note 2)

ISIN: US7170811035
Date of dealing

16 November 2015

 

 

 

2.         INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

 

Long

Short

 

 

Number                                     (%)

Number                                         (%)

(1) Relevant securities

 

108,916,396                      1.76%


(2) Derivatives (other than options)

 



(3) Options and agreements to purchase/sell

 



Total

 

108,916,396                      1.76%


 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security: 

 

Long

Short

 

 

Number                                     (%)

Number                                         (%)

(1) Relevant securities

 



(2) Derivatives (other than options)

 



(3) Options and agreements to purchase/sell

 



Total

 



 

 

3.         DEALINGS (Note 4)

 

(a)        Purchases and sales

 

Purchase/sale

 

Number of securities

Price per unit (Note 5)

Purchases

 

 

 

5,200

1,000

2,000

3,800

32.945 USD

32.978 USD

33.105 USD

33.160 USD

 

 

(b)        Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

 

 




 

 

 

(c)        Options transactions in respect of existing securities

(i)         Writing, selling, purchasing or varying

 

Product name,

e.g. call option

 

Writing, selling,  purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price

Type, e.g. American, European etc.

Expiry

date

Option money

paid/received per unit (Note 5)








 

 

(ii)        Exercising

 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

 



 

 

 

(d)        Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8)

 

Details

Price per unit (if applicable) (Note 5)




 

 

 

 

 

 

 

 

 

 

4.         OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.  If none, this should be stated. 

 

None

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                                 NO

 

 

Date of disclosure

17 November 2015
Contact name

Gary Greb
Telephone number

001 410 345 2527

If a connected EFM, name of offeree/offeror with which connected


If a connected EFM, state nature of connection (Note 10)


 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEUBAVRVAAAAAA
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Pfizer.
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Pfizer.